Clinical Trial Update: MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing MVA85A aerosol vs intramuscular vaccination in adults with latent TB infection; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: TERMINATED | Results posted: 2020-08-31